Open AccessPCSK9, a novel target for lowering LDL cholesterol: promise and progress
Author(s) -
Hagai Tavori,
Sergio Fazio,
MacRae F. Linton
Publication year - 2012
Publication title -
clinical lipidology
Language(s) - English
Resource type - Journals
eISSN - 1758-4299
pISSN - 1758-4302
DOI - 10.2217/clp.12.72
Subject(s) - pcsk9 , ezetimibe , familial hypercholesterolemia , medicine , ldl receptor , placebo , monoclonal antibody , statin , cholesterol , pharmacology , clinical trial , endocrinology , antibody , lipoprotein , immunology , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom